Disclosures for "Hospital Course of Acute Ischemic Stroke in Patients with Infective Endocarditis: A Retrospective Cross-sectional Analysis"
-
Mr. Li has nothing to disclose.
-
Mr. Malhotra has nothing to disclose.
-
Mr. Syed has nothing to disclose.
-
Mr. Sinton has nothing to disclose.
-
Ms. Armoyan has nothing to disclose.
-
Miss Jain has nothing to disclose.
-
Mr. Gozum has nothing to disclose.
-
Miss Al-Mufti has nothing to disclose.
-
Mrs. almufti has nothing to disclose.
-
Dr. Karp has nothing to disclose.
-
Dr. Okafo has nothing to disclose.
-
Dr. Medicherla has nothing to disclose.
-
Dr. Rosenberg has nothing to disclose.
-
Dr. Bauerschmidt has nothing to disclose.
-
Dr. Kaur has nothing to disclose.
-
Dr. Chong has nothing to disclose.
-
Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ISchemaView. Dr. Mayer has stock in Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
-
Dr. Yaghi has nothing to disclose.
-
Chirag Gandhi has nothing to disclose.
-
Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .